Chloramphenicol Palmitate USP from Japan
Chloramphenicol palmitate, the palmityl ester derivative of chloramphenicol, meeting USP pharmacopeia standards for oral suspension preparation. Classified under HTS 2941.40.00.00 as a derivative and salt of chloramphenicol per the specific antibiotic subheading. This lipid-soluble prodrug converts to active chloramphenicol in the body.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide pharmacopeial compliance docs (USP/EP certificate) and stability data for ester integrity during shipping
• Avoid wooden pallets; use temperature-controlled containers to prevent palmitate hydrolysis above 30°C
• Declare exact ester content; mislabeling as base form triggers reclassification to Chapter 30 medicaments